Kailera Therapeutics, Inc.

US$12.97As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KLRAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$1.684B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
17.88%
(69.80%)
Hold 5|9|4|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.17
0.16
0.16
0.16
23.62%
15.02%
2.20%
(4.98%)
Revenue$M
107.5
106.3
106.0
112.2
9.42%
4.00%
5.99%
8.19%
Peers (US$1.684B)
Cap (US$)
PE
1.672B
5.690x
1.673B
—
Capital
TTM
5Y
10Y
Leveragex
2.829
0.144
0.132
EBIT/Intx
0.398
0.301
0.308
Own earn%
(54.54)
28.15
29.26
Sh yield%
48.07
41.31
39.97
Owners
Insiders/Inst%
5.16
53.91
Short interest%
2.29
SBC / revenue%
2.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
18–26
$1 testx
—
Incr. ROIC%
21